Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2023-08-22
2025-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treating Anxiety After Stroke (TASK)
NCT03439813
Preventing Chronic Depression and PTSD in Stroke Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Family Caregivers
NCT02797509
Mindfulness-Based Stress Reduction to Improve Neuropsychological Functioning in Acquired Brain Injury
NCT03969563
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
NCT05157880
Wellness Programs for Brain-Injured Individuals
NCT02600637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients discharged following acute care stroke
Participation will last 3 months from enrollment. Demographic data will be retrieved from the electronic health record and the Generalized Anxiety Disorder-7 (GAD-7) Anxiety Questionnaire will be administered at baseline. Participants will repeat the GAD-7 in 3 months and an additional qualitative survey on their experience including an evaluation of the structured anxiety reduction program.
Anxiety Reduction Bundle
The Anxiety Reduction Bundle intervention comprises the following resources:
* Stroke Support Group
* Anxiety Reduction Sheet
* Understanding Anxiety Disorder sheet
* Your body's response to anxiety sheet
* Relaxation Tip sheet
* Breathing Tip sheet and video
* A sigh of Relief video
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anxiety Reduction Bundle
The Anxiety Reduction Bundle intervention comprises the following resources:
* Stroke Support Group
* Anxiety Reduction Sheet
* Understanding Anxiety Disorder sheet
* Your body's response to anxiety sheet
* Relaxation Tip sheet
* Breathing Tip sheet and video
* A sigh of Relief video
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak, read and write in English
* Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
* Discharged to home
* Internet access including email
* Willingness to participate in an anxiety reduction program
* Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
* Must be medically stable
Exclusion Criteria
* Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
* Not discharged to home
* No internet access including email
* Unwilling or unable to participate in an anxiety reduction program
* Cognitively impaired
* Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
* Not medically stable
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bibi Sangster
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-00759
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.